ProShares UltraShort Nasdaq Biotechnology (BIS) Holdings $17.29 +0.27 (+1.59%) As of 06/13/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestTrendsBuy This Stock Top 7 BIS HoldingsRankCompanyCurrent PriceWeightShares Held1NET OTHER ASSETS (LIABILITIES)N/A0.00%2,549,4882TREASURY BILLN/A0.00%100,0003NASDAQ BIO INDEX SWAP BNP PARIBASN/A-34.69%-2164NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGN/A-39.51%-2465NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEN/A-41.12%-2566NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAN/A-41.92%-2617NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAN/A-42.72%-266 Geographic ExposureUnited States3.9%Currency ExposureUSD91.2% Related Companies and Tools Related Companies JPMorgan Healthcare Leaders ETF Holdings Horizon Kinetics Medical ETF Holdings First Trust Nasdaq Pharmaceuticals ETF Holdings Invesco Nasdaq Biotechnology ETF Holdings Global X HealthTech ETF Holdings ProShares Ultra Nasdaq Biotechnology Holdings F/m Emerald Life Sciences Innovation ETF Holdings Invesco Dorsey Wright Healthcare Momentum ETF Holdings Invesco S&P SmallCap Health Care ETF Holdings VanEck Biotech ETF Holdings This page (NASDAQ:BIS) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIS Stock Free BIS Stock Alerts